No menu items!

Efficacy of Cuban formulas opens hopes for first Latin American Covid-19 vaccine

RIO DE JANEIRO, BRAZIL - The efficacy achieved in clinical trials by two of Cuba’s formulas against covid-19, 62%, and 92%, is bringing closer the possibility of one of them becoming the first vaccine of this type developed in Latin America.

The preliminary results of the third and last stage of tests of the vaccine candidates Soberana 02 and Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content